The historical rank and industry rank for PositiveID's EV-to-EBIT or its related term are showing as below:
PSID's EV-to-EBIT is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 21.36 * Ranked among companies with meaningful EV-to-EBIT only.
The historical data trend for PositiveID's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, PositiveID's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PositiveID's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PositiveID's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where PositiveID's EV-to-EBIT falls into.
PositiveID EV-to-EBIT Calculation
PositiveID's EV-to-EBIT for today is calculated as:
PositiveID's current Enterprise Value is $0.00 Mil.
PositiveID's EBIT for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.76 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PositiveID (OTCPK:PSID) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
PositiveID's Enterprise Value for the quarter that ended in Mar. 2018 was $7.54 Mil.
PositiveID's EBIT for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.76 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PositiveID EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of PositiveID's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
PositiveID Corp is a life science tools and diagnostics company. It specializes in the biological detection and molecular diagnostic systems for homeland defense and the global healthcare market. The business activity of the firm includes the development of microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need through its subsidiary. Further, it is also involved in the development of FireflyDX family of products, automated pathogen detection system for rapid diagnostics, both for clinical and point-of-need applications. In addition, it also manufactures specialty technology vehicles focused primarily on mobile laboratory and communications applications. All the activities are carried out through the US.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PSID has been successfully added to your 